Home/Filings/4/0001209191-09-037098
4//SEC Filing

Royal Mike A 4

Accession 0001209191-09-037098

CIK 0001333248other

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 4:49 PM ET

Size

6.2 KB

Accession

0001209191-09-037098

Insider Transaction Report

Form 4
Period: 2009-07-16
Transactions
  • Award

    stock option (right to buy)

    2009-07-16+10,00010,000 total
    Exercise: $11.00Exp: 2019-07-15common stock (10,000 underlying)
Footnotes (2)
  • [F1]25% of the number of shares of common stock subject to the option vest one year after the date of grant, and 1/48th of the original number of shares of common stock subject to the option vest on the first day of each full month thereafter for so long as the Optionee continues to provide service to the Corporation; provided, however, that upon the U.S. Food and Drug Administration approval of the Corporation's New Drug Application for intravenous acetaminophen, 100% of such shares shall vest immediately.
  • [F2]Not applicable to this transaction.

Issuer

CADENCE PHARMACEUTICALS INC

CIK 0001333248

Entity typeother

Related Parties

1
  • filerCIK 0001378551

Filing Metadata

Form type
4
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:49 PM ET
Size
6.2 KB